Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

High mortality among patients hospitalized for drug‐resistant tuberculosis with acquired second‐line drug resistance and high HIV prevalence

HIV Medicine(2022)10.1111/hiv.13318Source: DataRank Database

High mortality among patients hospitalized for drug‐resistant tuberculosis with acquired second‐line drug resistance and high HIV prevalence is a research paper published in HIV Medicine (2022). On theSindex it has a DataRank of 0. It has been cited 10 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access10 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (13 grants)OA: hybridTopics (33)IDs (PubMed, PMC)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Elize Pietersen ORCID,Bryan E. Shepherd ORCID,Aihua Bian,Keertan Dheda ORCID,Robin M. Warren ORCID

Live enrichment

PubMed:35608016 PMC:PMC9588462

Medical Research Council

Grant: MR/S03563X/1

A lung-oriented controlled human infection model using live BCG to evaluate tuberculosis immunopathogenicity and vaccine efficacy (TB-CHIM).

NIAID NIH HHS

Grant: R01 AI158605

NIAID NIH HHS

Grant: K08 AI106420

Wellcome Trust

Grant: unidentified

unidentified

National Institutes of Health

Grant: 5P30AI110527-04

Tennessee Center for AIDS Research (TN-CFAR)

National Institutes of Health

Grant: 5K08AI106420-04

Fluoroquinolone resistance in patients with multidrug-resistant tuberculosis

National Institutes of Health

Grant: 5UL1TR002243-05

Vanderbilt Institute for Clinical and Translational Research (VICTR)

National Institutes of Health

Grant: 3R01AI158605-05S1

Poor Treatment Response and Outcomes in Bedaquiline-Based Treatment Regimens for Drug-Resistant Tuberculosis in South Africa

South African Medical Research Council

European & Developing Countries Clinical Trials Partnership (EDCTP)

Medical Research Council

Wellcome Trust

National Institutes of Health

hybridLicense: cc-by

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/hiv.13318

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1111/hiv.13318

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1111/hiv.13318

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9588462

https://doi.org/10.1111/hiv.13318

Fields of Study

03 medical and health sciences0302 clinical medicine

MeSH Terms

HumansTuberculosis, Multidrug-ResistantHIV InfectionsIsoniazidFluoroquinolonesRifampinAntitubercular AgentsPrevalenceRetrospective StudiesDrug ResistanceAdultFemaleMale

Keywords

MortalityHIVacquired resistanceDrug-resistant TuberculosisAdultMaleAntitubercular AgentsDrug ResistanceHIV InfectionsOriginal ArticlesTuberculosis, Multidrug-ResistantIsoniazidPrevalenceHumansFemaleRifampinFluoroquinolonesRetrospective Studies

Sustainable Development Goals

SDG 3: 3. Good health

High mortality among patients hospitalized for drug‐resistant tuberculosis with acquired second‐line drug resistance and high HIV prevalence

FAIR Checklist

Authors (8)

Funding (13 grants)

Open Access

Topics

Annotations (Europe PMC)